Array Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

ARRY 2.55 0.00 (0.00%)
price chart
Array Biopharma Inc (ARRY) Sees Large Decrease in Short Interest
Array Biopharma logo Array Biopharma Inc (NASDAQ:ARRY) saw a significant drop in short interest during the month of January.
Array BioPharma Inc. (ARRY) Hits New 52-week Low During February 11 Session
Array BioPharma Inc. (ARRY) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $2.45, Array BioPharma Inc. dropped to $2.39 for a new 52-week low. By the closing bell, the company's stock was at ...
Latest Analysts Reports On Array BioPharma Inc. (ARRY)  Risers & Fallers
3 Biotech Stocks Worth Chasing - Incyte Corporation (INCY), Cerus ...  iStreetWire
Array BioPharma (ARRY) Is Today's Strong On High Volume Stock
Despite the company's weak debt-to-equity ratio, the company has managed to keep a very strong quick ratio of 3.51, which shows the ability to cover short-term cash needs.
Array BioPharma Inc. (ARRY) Hits New 52-week Low During February 09 Session
Array BioPharma Inc. (ARRY) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $2.53, Array BioPharma Inc. dropped to $2.42 for a new 52-week low. By the closing bell, the company's stock was at ...
Array BioPharma Inc. (NASDAQ:ARRY) Analyst Ratings and Target Update  Uptick Analyst
Array Biopharma Inc (ARRY) Issues Earnings Results, Misses Expectations By $0 ...
Array Biopharma logo Array Biopharma Inc (NASDAQ:ARRY) posted its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.11, ...
Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2016  PR Newswire (press release)
Analyst Activity: Array Biopharma Inc  CWRU Observer
Why Shares in Array BioPharma, Inc. Are Soaring Higher
What: Shares in Array BioPharma (NASDAQ:ARRY) are rallying by more than 10% after the company released its first quarter financial results and offered up insight into its pipeline.
Cantor Fitzgerald Remains Positive on Array Biopharma Inc Following ...  Smarter Analyst
Array BioPharma's (ARRY) CEO Ron Squarer on Q3 2015 Results -- Earnings ...  Seeking Alpha
Array Biopharma Inc (ARRY) Short Interest Down 10.3% in December
Array Biopharma logo Array Biopharma Inc (NASDAQ:ARRY) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 23,339,973 shares, a decrease of 10.3% from the December 15th total of ...
Array BioPharma Inc. (ARRY) Hits New 52-week Low During January 19 Session  Equities.com
Steady Stock Movements: Array Biopharma Inc  iStreetWire
Array BioPharma And Pierre Fabre Announce Development And Commercialization ...
BOULDER, Colo., Nov. 16, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced a collaboration to globally develop and commercialize Array's late-stage novel oncology products, binimetinib and encorafenib.
Pierre Fabre lands ex-US rights to Array's Mek-BRAF combo in $455M deal  BioWorld Online
Moving on from Novartis, Array inks a $455M oncology deal with Pierre Fabre  FierceBiotech
Array BioPharma Inc. (ARRY) Hits New 52-week Low During February 08 Session
Array BioPharma Inc. (ARRY) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $2.88, Array BioPharma Inc. dropped to $2.59 for a new 52-week low. By the closing bell, the company's stock was at ...
Analyst's Roundup: Array Biopharma Inc  CWRU Observer
Stifel Nicolaus Maintains Array Biopharma Inc to Buy with Price Target $7.00  Street Edition
Array BioPharma Inc. (ARRY) Hits New 52-week Low During February 01 Session
Array BioPharma Inc. (ARRY) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $3.07, Array BioPharma Inc. dropped to $2.94 for a new 52-week low. By the closing bell, the company's stock was at ...